While these examples provide insights into some of attributed to failed neural tube closure. This mutation the factors that determine neurulation, they provide limis designated shroom (shrm) because the neural folds ited information regarding the identity and regulation "mushroom" outward and do not converge at the dorof the intrinsic structural molecules that facilitate the sal midline. shrm encodes a PDZ domain protein that conversion of the neural plate into the neural tube. This is involved at several levels in regulating aspects of extensive remodeling necessitates coordinated changes cytoarchitecture. 
of the observation that the neural folds "mushroom" away from the dorsal midline, this mutation has been This report describes the identification and characterization of shroom (shrm), a mouse mutation that causes designated shroom (shrm). To characterize the shrm phenotype, mutant embryos exencephaly, acrania, facial clefting, spina bifida, and herniation of internal organs. The shrm gene is exfrom embryonic day (E) 8.25 to E17.5 were isolated and analyzed. Most shrm embryos are viable at all embryonic pressed in the neuroepithelium, the ventrolateral body wall, and the gut, suggesting these phenotypes result stages, indicating that shrm mutants survive to term but probably died during or very shortly after birth. Mutant directly from a loss of Shrm protein. shrm encodes a PDZ domain-containing cytoskeletal protein that can embryos can be distinguished phenotypically by E9.25, as the lateral edges of the cranial neural folds are wavy directly bind F-actin and regulate its subcellular distribution in cells. In addition, we show that cytoskeletal polarin appearance and have not converged at the dorsal midline ( Figure 1A ). By E10.25 the phenotype is manifest ity is perturbed in Shrm-deficient neuroepithelium. Taken together, these results suggest a cytoskeletal basis for as an open neural tube that extends rostrally from the otic vesicle ( Figures 1B-1D and 1H ). Occasionally, dethe severe NTDs observed in shrm mutant embryos. fects in caudal neural tube closure occur, resulting in and forebrain ( Figure 2D ). The expression pattern determined by X-gal staining has been confirmed by wholespina bifida ( Figure 1C, arrowhead) . Histological analymount RNA in situ hybridization using a probe to the sis and scanning electron microscopy of transverse sectrapped gene (data not shown). tions through E10.25 shrm mutant embryos show that the neural tube is malformed along the entire AP axis shrm Embryos Are Patterned Correctly and the forebrain neuroepithelium is exposed (Figures There are several possible mechanisms that could ex-1F and 1J). Specifically, the neural tube is foliated, and plain the NTDs observed in shrm mutant embryos, inthe roof plate is abnormal. Other midline structures and cluding abnormalities in patterning that act autonosurrounding tissues, such as the notochord, floor plate, mously within the neuroepithelium. The expression of head mesenchyme, and somites, appear normal in shrm shrm in the cranial neuroepithelium, but not in the head mutant embryos. By E14.5, failed neural tube closure mesenchyme, makes this a particularly realistic model. results in exencephaly, acrania, and facial clefting (FigConversely , based on the expression of shrm in the ure 1D). Some shrm mutants also display defects in paraxial mesoderm and the previous report that mesoventral closure, resulting in herniation of the intestine derm can play a role in patterning the neural tube and liver ( Figure 1D ).
(Grapin-Botton et al., 1998), it is possible that the caudal Not all of the observed phenotypes are fully penetrant.
NTDs observed in shrm mutant embryos are secondary While all homozygous mutant embryos exhibited exento a defect in paraxial mesoderm. To test these models, cephaly, 87% (68/78) of the E11.5-E17.5 mutant emwild-type and shrm mutant embryos were assayed by bryos exhibited definitive craniofacial clefting, and 23% whole-mount RNA in situ hybridization or immunostain-(21/93) of the E10.5-E17.5 mutant embryos displayed ing to detect alterations in patterning. Probes to wnt3A spina bifida. A small number, 8% (21/279), of heterozy-( Figures 3A and 3B) , wnt1, krox20, and sonic hedgehog gous embryos displayed a much less severe form of (data not shown) were used to assess patterning of the exencephaly (data not shown). Finally, only 12% (7/59) neural tube and axial mesoderm; probes for twist ( ( Figure 3F ). The only notable difference is in the expression domain of wnt3A, which is slightly expanded and diffuse at the dorsal midline of mutant embryos (Figure Expression of shrm 3B). However, this expression pattern may be secondary The gene trap vector used to generate the shrm mutation to the abnormal roof plate and undulated nature of the contains a ␤-galactosidase reporter gene that should neural tube. In addition, it is well documented that alterbe expressed under the control of the trapped gene's ations in cranial neural crest cells can cause NTDs. To endogenous promoter. Therefore, heterozygous shrm determine whether the shrm phenotype results from a embryos were isolated and stained with X-gal to deterneural crest defect, we assayed the integrity of the cramine the temporal and spatial expression of the reporter. nial skeleton, as many of these structures are derived At E8.75, prior to the onset of the phenotype, intense from neural crest cells (reviewed in Le Douarin et al., staining is detected in the rostral portion of the embryo 1993). In mutant embryos, the bones comprising the in the cranial neuroepithelium (Figures 2A and 2E) . In cranial vault do not form, and while the bones that the trunk region at this stage, staining is seen in the make up the base of the skull are present, they tend to neural tube, the paraxial mesoderm, and the gut (Figures be slightly smaller and less well developed (data not 2A, 2E-2G). The robust expression of shrm in the neuroshown). It is likely that these defects are secondary to epithelium rostral to the otic vesicle, but not in the surthe exencephalic development of the brain. rounding head mesenchyme, correlates well with the NTDs can also result from an imbalance between cell temporal and spatial onset of the fully penetrant phenoproliferation and cell survival in the neural tube, paraxial types and strongly supports the hypothesis that Shrm mesoderm, and/or head mesenchyme. Therefore, wildacts autonomously within the neuroepithelium. At E10.5, type and mutant E9.75 embryos were assayed to deterexpression in the rostral portion of the embryo is localmine the relative amounts of apoptosis (data not shown) ized to the neural tube and forebrain (Figures 2B and and cell proliferation ( Figures 3G-3I ). These assays re-2H). In the trunk region, shrm expression is detected in veal no significant differences between wild-type and the neural tube, somites, ventral body wall, heart, and shrm mutant embryos, suggesting the phenotype is not gut ( Figures 2B, 2H-2J) . Interestingly, shrm expression related to aberrant cell proliferation or cell survival. Simiin the neural tube is quite dynamic, suggesting that only larly, by counting the nuclei in each of the tissues ascertain cells or processes require Shrm function during sayed, it appears that the total number on cells comprisneurulation. Specifically, shrm expression is limited to ing these compartments is unchanged in shrm mutant the floor and roof plates as development progresses embryos. In addition, histological analysis also sugbut appears more widespread during the formation of gested there were no overt abnormalities in the tissues the neural tube ( Figure 2H ). The strong expression of that surround and support the neuroepithelium (Figure shrm in the ventral body wall and gut is consistent with 1, data not shown). In order to more carefully evaluate the ventral closure defects exhibited by some mutant the formation of these tissues, wild-type and shrm muembryos. By E14.5 of development, shrm expression is tant embryos were viewed at high resolution using scanning electron microscopy ( Figures 1I, 1J, 3J , and 3K). restricted to the skeletal muscle, distal tips of the digits, Despite the fact that the neural tube is severely maltwo different putative protein products ( Figures 4A and  4B ). The longest predicted transcript, shrmL, encodes a formed, imaging at this resolution reveals no differences in the size, shape, or architecture of the tissues surprotein of 1986 amino acids, while the second transcript, shrmS, encodes a protein of 1808 amino acids that lacks rounding the neural tube.
In concert, these data suggest there are no alterations the N-terminal 177 amino acids of ShrmL. Based on the observation that the 5ЈRACE product was identical to in patterning, proliferation, or cell survival affecting either the neuroepithelium, head mesenchyme, or paraxial the 5Ј UTR of the shrmS transcript, we predict the gene trap insertion occurred 3Ј of the translational start site mesoderm that could account for the observed NTDs. In light of this information, it is possible the NTDs are for ShrmL, but 5Ј of the translational start site for ShrmS ( Figure 4A ). Therefore, the observed X-gal staining may caused by a structural or mechanical defect that acts autonomously within the cells comprising the neural represent the expression of shrmS. However, RNA in situ hybridization indicates that most cells may normally tube. This is supported by the observation that shrm is exclusively expressed in the cranial neural folds, but not express both ShrmS and ShrmL (data not shown). Analysis of the protein sequence indicates that shrm in the surrounding head mesenchyme, and this tissue is affected in 100% of the mutant embryos observed.
belongs to a gene family consisting of shrm, apx, and APXL ( Figures 4B-4E ). Apx, which appears to be a comFurthermore, as shrm is expressed in the caudal neuroepithelium, the mechanism that causes the cranial deponent or regulator of amilioride-sensitive sodium channels, was identified by expression cloning using an antifects may also cause the caudal defects.
body that recognized the apical surface of Xenopus epithelial cells (Staub et al., 1992) . APXL is a human shrm Encodes a Novel PDZ Domain Protein The cDNA for the trapped gene was cloned using gene named for its similarity to apx ( Figures 4D and 4E) . using antibodies to the PDZ domain and Northern blot These domains, ASD1 and ASD2 (Apx/Shrm domain), analysis using nucleotides 632-2534 as a probe detects share no homology with other known proteins and have no shrm mRNA in mutant embryos (data not shown). no identified function. Shrm and APXL are 52% and 60% Thus, we predict this mutation causes a null allele for identical in ASD1 and ASD2, respectively, while Shrm shrmL and shrmS. and Apx are 35% and 45% identical in ASD1 and ASD2.
In an effort to understand the cell biological role of Finally, Shrm contains two peptide motifs that might be shrm, we employed indirect immunofluorescence to animportant for its function: (1) a putative PDZ domainalyze the subcellular distribution of endogenous Shrm binding site at its C terminus consisting of the sequence protein in both primary cells derived from wild-type neuSer-Pro-Leu ( Figure 4E Figure 5F ), or F-actin ( Figure 5H ). These exthat the trapped allele was protein null, polyclonal antibodies to the C terminus were generated and used for periments reveal colocalization of Shrm with vinculin 1-1264 (Figures 6D-6F) (Figures 7A-7C) . Similarly, a portion of Shrm consisting only of amino acids 754-953 is also targeted F-actin. It is known that the PDZ domain of Shrm does not participate in actin localization, as ShrmS is targeted to actin stress fibers, albeit somewhat less efficiently than ShrmL (Figure 7D-7F) , suggesting the actin tarto actin stress fibers and a fragment of Shrm containing amino acids 1-711 is cytosolic (data not shown). To geting sequence is located within these amino acids. GST754-953 (lanes 3 and  4) or GST1474-1986 (lanes 1 and 2) . Quantification of the interaction between GST754-953 and F-actin is shown in (K). Arrow, GST754-953; arrowhead, GST1474-1986; double arrowhead, actin. determine whether Shrm localization is due to a direct dress this hypothesis, we assayed the subcellular distribution of F-actin, ␤-catenin, and cortactin in the neurointeraction with F-actin, we assayed a GST fusion protein containing amino acids 754-953 of Shrm for the epithelium of wild-type and mutant E9.75 embryos. In wild-type embryos, ␤-catenin ( Figure 8A ) and F-actin ability to bind F-actin in a cosedimentation experiment ( Figure 7J ). In these experiments, GST754-953 is found ( Figure 8AЈ ) are colocalized ( Figure 8AЈЈ ) at the apical surface of the neuroepithelium. In shrm mutant embryos, in the pellet, indicating it can directly bind F-actin ( Figure  7, lane 4, arrow) . Conversely, a GST fusion protein conhowever, ␤-catenin and F-actin are poorly localized to the apical surface and are more diffuse (Figures 8B-taining amino acids 1474-1986 of Shrm is found only in the supernatant fraction and not in the F-actin pellet 8BЈЈ). Likewise, the apical localization of cortactin, a cortical actin-binding protein, is also significantly re-( Figure 7J, lanes 1 and 2, arrowhead) . No fusion protein is precipitated in the absence of F-actin (data not duced in shrm mutant embryos ( Figures 8D and 8F ) as compared with wild-type embryos ( Figure 8C and 8E) . shown). Initial analysis to determine the kinetics of this interaction suggests the binding is saturable ( Figure 7K) .
Figure 6. Shrm Recruits Actin to Ectopic Sites

MLP-29 epithelial cells expressing ShrmL (A-C), Shrm1-1264 (D-F), or Shrm1-1264 ActA (G-I) were labeled to detect Shrm (A, D, and G,) and F-actin (B, E, and H); merge (C, F, and I). Boxed regions in (A)-(C) and (G)-(I) are enlarged (insets) to show
Costaining of these sections with DAPI to localize nuclei did not reveal significant alterations in the overall apicalThese results, in conjunction with those in the previous section, suggest that Shrm is an F-actin-binding protein basal polarity of these cells, indicating that the observed defects may affect only specific aspects of cellular orgathat can recruit existing actin filaments to ectopic sites in the cell.
nization. To further determine whether the shrm phenotype is due to an autonomous defect in the cytoskeletal polarity
Shrm as a Determinant of Cytoskeletal Polarity
The above results suggested a cytoskeletal basis for of the neuroepithelium, the cranial neural folds from E8.75-E9.0 (12-15 somites) wild-type and mutant emthe NTDs exhibited by shrm mutant embryos. To ad- This report describes the identification and characterization of a recessive lethal mouse mutation designated phenotypically indistinguishable, and there were no obvious differences between mutant and wild-type tissues shrm. The primary defect exhibited by shrm mutant embryos is a pronounced failure in proper neural tube following in vitro culture (data not shown). After 36 hr of growth in vitro, the tissues were sectioned and stained morphogenesis. Several lines of evidence suggest that shrm acts autonomously within the neuroepithelium to with phalloidin to determine the status of the actin cytoskeleton. In wild-type samples, actin is predominantly facilitate neurulation at the level of cellular cytoarchitecture. First, shrm is strongly expressed in the rostral localized to the apical surface, indicating the overall cytoskeletal polarity of the neural epithelium is mainneuroepithelium at the time of cranial neural tube closure and is not expressed in the surrounding head mesentained in culture ( Figure 8G ). Due to atypical development in culture, the apical localization of actin in the chyme. Importantly, this region of the neural tube is affected in 100% of the shrm mutant embryos examined. wild-type cultures is slightly perturbed relative to that observed in vivo. In mutant samples grown in culture, It is interesting that shrm expression within the neuroepithelium is quite dynamic, suggesting that the activity however, the subcellular distribution of F-actin is significantly shifted away from the apical surface, similar to of Shrm may be required for only some aspects of neural tube closure or in specific cell types within the neurowhat is seen in shrm mutant embryos in vivo ( Figure  8H ). Together, these data indicate that Shrm is involved epithelium. At E8.75-E9.25 shrm is expressed uniformly in the neural tube rostral to the otic vesicle, while expresin cytoskeletal architecture and its activity is a critical intrinsic factor of neural tube closure.
sion is restricted to the floor and roof plates of the neural tube caudal to the otic vesicle. The expression of shrm PDZ domain function, and the known mechanisms of regulating cell shape and adhesion, it is tempting to in the roof plate is interesting, as this is the site where fusion of the neural folds occurs and shrm mutant empredict that Shrm is a multifaceted adaptor protein that acts to determine cytoskeletal polarity or architecture. bryos display defects in this process. Second, in contrast to many of the existing mouse mutants that exhibit For example, the PDZ domain could bind the cytoplasmic tail of a membrane receptors while the actinabnormal neurulation, the shrm mutation does not affect patterning or growth in either the neuroepithelium or binding region directly interacts with F-actin. This type of interaction could have at least two possible consethe surrounding tissues. Third, we show that Shrm is a cytoskeletal protein that can directly bind F-actin and quences. In one scenario, this interaction may serve to define cytoarchitecture by anchoring actin stress fibers control its subcellular distribution. Finally, in shrm mutant embryos, cells comprising the neuroepithelium disto the plasma membrane. Conversely, Shrm could function to confine the subcellular distribution of membrane play clear cytoskeletal defects. Embryos were isolated and treated with a mixture of Dispase/Collagenase (Boehringer Mannheim) at 1 mg/ml in PBS for 15 min at 4ЊC followed by 7 min at 37ЊC. Neural tubes were broken up into smaller Experimental Procedures pieces and plated onto fibronectin-coated coverslips. Neural tubes were cultured for 3-4 days in DMEM/10% fetal bovine serum (FBS).
Gene Trap Vectors and ES Cells
Alternatively, neuroepithelial cells were isolated and grown in A gene trap cassette, SA␤galCrepA, containing an adenovirus splice DMEM/10% FBS supplemented with 20 ng/ml FGF-2 (Boehringer acceptor (Friedrich and Soriano, 1991), a bifunctional gene fusion Mannheim) and 8 g/ml heparin as described (Kilpatrick and Bartbetween ␤-galactosidase (␤-gal) and the Cre recombinase, and the lett, 1993). After 24 hr, cells were replated and grown in the presence MC1 polyadenylation (pA) sequence (Thomas and Capecchi, 1987) of FGF-2. Colonies of cells exhibiting an epithelial morphology were was generated. This cassette was cloned into pGen Ϫ (Soriano et isolated, pooled, expanded, and tested by either X-gal staining or al., 1991) to make the retroviral vector ROSA-␤galCre (ROSA, reverse immunofluorescence staining to determine whether they retained orientation splice acceptor). ROSA-␤galCre was introduced into the shrm expression. These cells were then assayed for cytoskeletal packaging line GPϩE86 as described (Soriano et al., 1991) . Virus architecture, formation of adhesion structures, and adhesion to ECM was harvested and used to infect AK7 ES cells harboring a reporter components. that selects for Cre activity. ES cells harboring gene trap insertions For in vitro culture of neural tissue, neuroepithelium was dissected were used to generate chimeric mice by blastocyst injection, and away from the majority of the surface ectoderm and mesenchyme germline transmission was achieved by mating male chimeric mice following dispase/collagenase digestion for 10 min at 4ЊC followed to wild-type females.
by 4 min at 37ЊC. Isolated neuroepithelium was imbedded in collagen gel (Collaborative Biomedical) and grown in Hams F12 suppleCloning of shrm mented with N2 supplement (GIBCO-BRL), glutamine, and antibiot-5Ј-RACE was carried out using RNA from mutant embryos as deics for 36 hr at 37ЊC. scribed (Frohman et al., 1988) . The ␤-gal gene-specific primers (GSP) used were as follows: GSP1, 5Ј-CCGTGCATCTGCCAGT Histology TTGAGGGGA-3Ј; GSP2, 5Ј-CGACGACAGTATCGGCCTCA-3Ј; and For X-gal staining, embryos were fixed and stained as described GSP3, 5Ј-CAGCTTTCCGGCACCGCTTC-3Ј. The gene nonspecific (Friedrich and Soriano, 1991). Embryos used for histology were fixed primers used were as follows: Q T , 5Ј-CCAGTGAGCAGAGTGAC in 4% PFA at 4ЊC, dehydrated in ethanol, cleared in Histoclear (Na-GAGGACTCGAGCT CAAGC(T)17-3Ј; Q 0 , 5Ј-CCAGTGAGCAGAGT tional Diagnostics), and embedded in paraffin. Five-micrometer sec-GACG-3Ј; and Q 1 , 5Ј-GAGGACTCGAGCTCAAGC-3Ј. A 240-base tions were mounted on TESPA-coated slides, dewaxed, hydrated, pair (bp) fragment was isolated and used to screen a mouse brain and stained with Harris hematoxylin and eosin-Y (H&E). For immunocDNA library (Stratagene, La Jolla, CA). One clone (1) was isolated fluorescence, embryos were fixed in 4% PFA at 4ЊC, dehydrated in and sequenced. 1 contained 120 bp of sequence identical to the ethanol, cleared in xylene, and embedded in paraffin. Four-microme-5Ј-RACE product and 380 bp of unique sequence and was used to ter sections were dewaxed and hydrated in PBS prior to addition of screen the brain library and an ES cell cDNA library to obtain further antibody. Ten-micrometer frozen sections of embryos and collagen 5Ј and 3Ј sequence. Mice harboring the mutation are genotyped by gels were prepared as described (Koleske et al., 1998). Scanning Southern blot using the 5ЈRACE product, which identifies a restricelectron microscopy was carried out following a previously detion fragment polymorphism caused by the insertion (data not scribed technique (Stanisstreet, 1990 ). shown). MacVector and ClustalW were used for sequence analysis Whole-mount RNA in situ hybridization and immunohistochemisand alignments. try was performed as described (Hogan et al., 1994) using the following probes: twist 3Ј UTR (R. Behringer), wnt3A (H. Roelink), 800 bp Antibodies, Western Blotting, and Immunofluorescence fragment from krox20 (W. Shawlot), a 2.5 kb fragment of rat sonic Chicken anti-Shrm antibodies were generated against GST fusion hedgehog (H. Roelink), the 3ЈUTR of PDGF␣ receptor (M. Tallquist proteins containing amino acids 1-250 (ShrmN) or amino acids et al., unpublished data), rabbit anti-Mox1 serum (C. Wright and 1474-1986 (ShrmC) by Aves Labs. To immunoprecipitate Shrm, af-A. Candia), and anti-neurofilament mAb 2H3 (T. Jessell). TUNEL finity-purified anti-ShrmC (1:100) was added to 500 g total cell analysis, to detect apoptosis, and BrdU incorporation, to detect lysate in 1 ml of RIPA lysis buffer derived from mutant or wild-type proliferating cells, were performed as described (Soriano, 1997). embryos and incubated at 4ЊC for 1 hr. Shrm immune complexes were collected with rabbit anti-chicken IgY (Jackson Immunoresearch) bound to protein A-Sepharose 4B (Pharmacia) and washed
Expression of Shrm Variants
The following Shrm constructs were generated and used for expresthree times with RIPA and twice with TBS at 4ЊC. Shrm was detected by Western blot with anti-ShrmC (1:500 dilution), HRP-conjugated sion in eukaryotic cells or bacteria. A cDNA encoding ShrmL (1-1986) was assembled and cloned into the expression vector pCS2. Shrm1-goat anti-chicken (1:2500, Jackson Immunoresearch), and ECL reagent (Amersham).
1264 was generated by cloning DNA encoding amino acids 1-1264 into pCS2. Shrm1-1264actA was generated by cloning cDNA encodIndirect immunofluorescence on cells and sections was performed using affinity-purified anti-ShrmC (1:25 
